Self -proclaimed personal retirement (SIPP) is one of the vehicles that many investors exploit to build wealth in a long term.

Considering the time frame involved, it can be a successful strategy. For example, within 20 years, a elaborate annual growth rate (CAGR) of 3.6% would be sufficient to double the value of SIPP.

It is not far from the current average FTSE 100 capacity 3.4%. Dividends can augment the augment in share prices, although of course falling share prices may negatively affect CAGR. In addition, dividends are never guaranteed.

Despite this, as part of the diverse SIPP, I think that there are many shares to consider for investors who want to double the value of their SIPP in the long term.

Here are three of them.

British American Tobacco

To start with, British American Tobacco (LSE: Bats) offers an attractive 6.5%performance. In addition, dividends have grown up for decades.

Whether it can continue – and even simply maintaining a dividend – is a question that investors must seriously consider. The company not only has a lot of debt, but its basic cigarette market is still noticing the weakening demand in the long term.

However, although there is a clear risk, I also think that this high -performance participation has some clear attractions.

To start with, while the size of the sales of cigarettes is falling, they are still significant. Cheap, but steep to buy, it is a highly profitable business space, and thanks to the stable brands of Premium British American is able to download premium prices.

Legal and general

Another FTSE 100 High performance participation for SIPP investors to be considered Legal and general (LSE: LGGE).

It aims to augment the dividend to the action by 2% per year. This is a smaller augment than before, but there is still an augment. Even now, before any potential future increases, the performance is juicy 8.5%.

Thanks to the huge target market and a fixed customer base, the financial services company can exploit a mighty brand, as well as long market experience.

One risk I see is the sale of huge American business. It can be good for a compact -term generation of cash, but it threatens to leave the hole on the profit and loss account in future years. We hope that an augment in other areas can lend a hand legal and general fill it.

Bug

At 3.2%, packaging supplier Bug (LSE: BNZL) does not fit up to 3.6%, which I mentioned in my example above. 26% drop in stock price over the past year does not look promising either.

Over the next decades, I hope that the company will be able to develop dividends for the action each year. I also see the potential for increasing stock price.

Poor demand on key markets and increased costs of consuming profit margins remain a risk. But the proven Bunzla business model consisting in acquiring companies in order to build a scope, benefits of scale and becoming more and more attractive to global customers, in my opinion is convincing.

Apparently, the management has to do, starting from the reversal of a decrease in revenues in the last few years. If he can fix the ship, I think the current price of Bunzl shares looks like a potential opportunity. I recently added some Bunzl actions to my SIPP.